The US Food and Drug Administration (PDA) has approved rifapentine (Priftin) - the first new antituberculosis (anti-TB) drug to be licensed in 25 years. Rifapentine is indicated for pulmonary
multi-drug resistant tuberculosis (mdr-tb) may threaten India's health security, according to a study of the World Health Organisation (who). The problem already exists in Russia, Latvia, Argentina
A new strain of bacteria which causes tuberculosis (TB) and is resistant to traditional anti-TB drugs is emerging as a major hazard in Nepal. The new strain of bacteria called Multi
The number of drug-resistant tuberculosis (TB) cases is exploding in South Africa, according to Action TB, a research group funded by the British pharmaceuticals company Glaxo Wellcome. The
tuberculosis (tb), the giant killer, may be effectively contained with the help of a microbe Mycobacterium vaccae, which is closely related to the bacterium that causes the disease. Researchers
A three-day SAARC meeting from September 23-25 on tuberculosis (TB) and AIDS, spelt out country specific action plan for managing the diseases. The meeting which was held in Kathmandu, revealed that
for the millions suffering from tuberculosis, especially in the Third World countries, the development of a new vaccine offers a glimmer of hope. Scientists at the Medical Research Council, uk, have